About Cell Therapy Pharmaceuticals ShareThis Contact Us

Upcoming Events

Past Events

Neuralstem, Inc. at 9th Annual World Stem Cells & Regenerative Medicine Congress 2014

05/22/2014

11:35am BST

Location: London
Speaker: Richard Garr, President and CEO
Additional Information:
Track A: International Collaboration
Title: “Sustainable growth of regenerative medicine: ensuring long term development and patient access to transformative cell therapies”

Event link: http://www.terrapinn.com/conference/stem-cells/index.stm

Information for Investors

ShareThis Copy and Paste

ROCKVILLE, Md., Nov. 12, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported financial results for the three months and nine months ended September 30, 2013 and provided a business and clinical update. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) "The Company reached several major milestones in the third quarter. We completed patient dosing in our Phase Ib trial to treat major depressive disorder with NSI-189, our lead small molecule compound. We also ...